The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disord...
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review
About this item
Full title
Author / Creator
de Berardis, Domenico , Fornaro, Michele , Orsolini, Laura , Iasevoli, Felice , Tomasetti, Carmine , de Bartolomeis, Andrea , Serroni, Nicola , Valchera, Alessandro , Carano, Alessandro , Vellante, Federica , Marini, Stefano , Piersanti, Monica , Perna, Giampaolo , Martinotti, Giovanni and Di Giannantonio, Massimo
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Loxapine is a first generation antipsychotic, belonging to the dibenzoxazepine class. Recently, loxapine has been reformulated at a lower dose, producing an inhaled powder that can be directly administered to the lungs to treat the agitation associated with psychiatric disorders, such as schizophrenia and bipolar disorder. Thus, the aim of this nar...
Alternative Titles
Full title
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5343884
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5343884
Other Identifiers
ISSN
1422-0067,1661-6596
E-ISSN
1422-0067
DOI
10.3390/ijms18020349
